HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philipp Müller Selected Research

von Willebrand Factor

11/2020Functional investigation of the coronary artery disease gene SVEP1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philipp Müller Research Topics

Disease

15Neoplasms (Cancer)
04/2024 - 08/2014
3Breast Neoplasms (Breast Cancer)
01/2019 - 01/2015
2Atherosclerotic Plaque (Atheroma)
01/2023 - 10/2021
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 11/2020
2Atherosclerosis
01/2023 - 11/2020
2Temporal Lobe Epilepsy
01/2022 - 01/2017
2Inflammation (Inflammations)
01/2022 - 11/2015
2Lung Neoplasms (Lung Cancer)
10/2019 - 01/2015
2Tobacco Use Disorder (Nicotine Dependence)
06/2008 - 07/2005
2Hypertension (High Blood Pressure)
03/2008 - 01/2007
1Adenocarcinoma
04/2024
1Ischemic Stroke
11/2023
1Stroke (Strokes)
11/2023
1Brain Injuries (Brain Injury)
11/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2023
1Psychological Trauma
01/2023
1Epilepsy (Aura)
01/2022
1Multiple Sclerosis
11/2021
1Spinal Cord Injuries (Spinal Cord Injury)
11/2021
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
09/2020
1Mucopolysaccharidosis IV (Morquio Syndrome)
09/2020
1Enteritis
01/2020
1Seizures (Absence Seizure)
01/2017
1Virus Diseases (Viral Diseases)
01/2017
1Type 2 Diabetes Mellitus (MODY)
01/2016
1Gout
01/2016
1Inborn Genetic Diseases (Disease, Hereditary)
01/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Rheumatoid Arthritis
01/2016
1Melanoma (Melanoma, Malignant)
01/2015
1Calculi (Calculus)
12/2011
1Ataxia Telangiectasia (Louis Bar Syndrome)
03/2010

Drug/Important Bio-Agent (IBA)

3AntigensIBA
04/2024 - 08/2014
3Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2020
3Immunoconjugates (Immunoconjugate)IBA
01/2019 - 08/2014
3AntibodiesIBA
01/2018 - 01/2015
3VaccinesIBA
01/2016 - 07/2005
2Apolipoproteins E (ApoE)IBA
01/2023 - 11/2020
2B7-H1 AntigenIBA
08/2021 - 01/2015
2Ado-Trastuzumab EmtansineIBA
01/2019 - 11/2015
2CytokinesIBA
02/2016 - 01/2016
1Peptides (Polypeptides)IBA
04/2024
1Biomarkers (Surrogate Marker)IBA
11/2023
1DisintegrinsIBA
01/2023
1Metalloproteases (Metalloproteinases)IBA
01/2023
1Vesicular Neurotransmitter Transport ProteinsIBA
01/2023
1CollagenIBA
01/2023
1NMDA receptor A1IBA
01/2023
13,4-methylenedioxyethamphetamine (MDEA)IBA
01/2023
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2023
1durvalumabIBA
01/2023
1Peptide Hydrolases (Proteases)FDA Link
01/2023
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2022
1InflammasomesIBA
01/2022
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2021
1Epidermal Growth Factor (EGF)IBA
11/2020
1von Willebrand FactorIBA
11/2020
1Glycoside Hydrolases (Endoglycosidases)IBA
09/2020
1GalactosidasesIBA
09/2020
1Virulence Factors (Pathogenicity Factors)IBA
01/2020
1Therapeutic UsesIBA
10/2019
1AnthracyclinesIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Trastuzumab (Herceptin)FDA Link
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Axitinib (AG 013736)IBA
01/2018
1Glutamic Acid (Glutamate)FDA Link
01/2017
1Lorazepam (Ativan)FDA LinkGeneric
01/2017
1Kainic Acid (Kainate)IBA
01/2017
1AlarminsIBA
01/2017
1Bispecific AntibodiesIBA
02/2016
1Folate Receptor 1IBA
02/2016
1ParaffinIBA
01/2016
1Formaldehyde (Formol)FDA Link
01/2016
1Carbonic Anhydrase IXIBA
12/2015
1carbonic anhydrase XIIIBA
12/2015
1Blocking AntibodiesIBA
03/2015
1MicellesIBA
01/2015
1perchlorateIBA
01/2015
1CTLA-4 AntigenIBA
01/2015
1IpilimumabIBA
01/2015
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2015
1Brentuximab VedotinIBA
08/2014
1Caffeine (No Doz)FDA LinkGeneric
03/2010
1triethylene glycol dimethacrylate (TEGMA)IBA
03/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2010
1Phosphotransferases (Kinase)IBA
03/2010
1NicotineFDA Link
06/2008

Therapy/Procedure

5Immunotherapy
01/2018 - 06/2008
4Therapeutics
01/2019 - 01/2015
1Precision Medicine
11/2023
1Chemoradiotherapy
01/2023
1Spinal Cord Stimulation
11/2021
1Oral Administration
01/2015
1Drug Therapy (Chemotherapy)
09/2014
1Aftercare (After-Treatment)
12/2011
1Extracorporeal Shockwave Therapy
12/2011
1Subcutaneous Injections
03/2008